CLINICAL_TRIALS
research
· 2026-01-06
Clinical Trial Update: Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone [NA]
Summary
A clinical trial assessing a prophylactic regimen of intravenous oxytocin, intravenous tranexamic acid, and intramuscular methylergometrine for primary preventi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cairo University | Conditions: Post Partum Hemorrhage | NA | Status: NOT_YET_RECRUITING